webinar register page

The Critical Role of Monoclonal Antibodies as the COVID-19 Pandemic Continues
In the continued fight against the virus that causes COVID-19, we have seen how important monoclonal antibodies and other therapeutics are in helping prevent serious illness. As viral variants arise and spread, it is increasingly critical that healthcare providers who care for people at increased risk of developing severe COVID-19 symptoms have the latest treatment information at their fingertips. Dr. Michael Anderson with the HHS Office of the Assistant Secretary for Preparedness and Response, will share the latest information on the available COVID-19 therapeutics and address important updates such as the efficacy of the medications, new administration routes and novel treatments in the pipeline, fee reimbursement resources, provider and patient tools and fact sheets, and much more. Dr. Anderson will also be available for a Q and A to answer providers’ questions about these important COVID-19 therapies.

This webinar will now include the local perspective as we are joined by NYC Department of Health and Mental Hygiene. We will hear about some of the challenges and solutions in the education, promotion, and coordination of therapeutics. Additionally, NYC will share resources that have been developed to support their recent activities.

Sep 9, 2021 03:00 PM in Eastern Time (US and Canada)

Webinar is over, you cannot register now. If you have any questions, please contact Webinar host: NACCHO Preparedness.